Sigma Planning Corp cut its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 45.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,874 shares of the company’s stock after selling 9,034 shares during the period. Sigma Planning Corp’s holdings in Clorox were worth $1,766,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in CLX. Insight Folios Inc raised its holdings in shares of Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after purchasing an additional 63 shares in the last quarter. HCR Wealth Advisors raised its holdings in Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after buying an additional 68 shares in the last quarter. Empower Advisory Group LLC raised its holdings in Clorox by 4.5% during the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after buying an additional 78 shares in the last quarter. Aviance Capital Partners LLC raised its holdings in Clorox by 2.7% during the third quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after buying an additional 80 shares in the last quarter. Finally, Lindbrook Capital LLC raised its holdings in Clorox by 9.9% during the third quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock valued at $159,000 after buying an additional 88 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.
Analyst Upgrades and Downgrades
CLX has been the topic of a number of recent analyst reports. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. JPMorgan Chase & Co. lifted their price target on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Barclays lifted their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $158.21.
Clorox Stock Up 2.8 %
Shares of CLX stock opened at $157.41 on Monday. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock has a fifty day moving average price of $157.72 and a 200 day moving average price of $159.96. The stock has a market cap of $19.39 billion, a P/E ratio of 43.01, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42.
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the company posted $2.16 EPS. Analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Bank Stocks – Best Bank Stocks to Invest In
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- 10 Best Airline Stocks to Buy
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.